Packaging box
Latest NOVARTIS AG Patents:
- Tricyclic AKR1C3 dependent KARS inhibitors
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
The file of this patent contains at least one drawing/photograph executed in color. Copies of this patent with color drawing(s)/photograph(s) will be provided by the Office upon request and payment of the necessary fee.
Claims
The ornamental design for a packaging box, as shown and described.
2089067 | August 1937 | Myers |
D394383 | May 19, 1998 | Bradfield |
D433630 | November 14, 2000 | Lubineau-Bigot |
D503087 | March 22, 2005 | Dzwill |
D503614 | April 5, 2005 | Sax |
D607317 | January 5, 2010 | Collins |
D679582 | April 9, 2013 | Witte |
D687706 | August 13, 2013 | Akana |
D721575 | January 27, 2015 | Paboojian |
D743247 | November 17, 2015 | Solovov, Jr. |
D747186 | January 12, 2016 | Palmer |
D751378 | March 15, 2016 | Solovov, Jr. |
D751891 | March 22, 2016 | Solovov, Jr. |
D772053 | November 22, 2016 | Mayer |
D820672 | June 19, 2018 | Gray |
D833867 | November 20, 2018 | Perella |
D848834 | May 21, 2019 | Exner |
D848835 | May 21, 2019 | Exner |
D888551 | June 30, 2020 | Kim |
D890605 | July 21, 2020 | Nelson |
D894728 | September 1, 2020 | Dwork |
Type: Grant
Filed: May 17, 2018
Date of Patent: Feb 16, 2021
Assignee: NOVARTIS AG (Basel)
Inventor: Ian Andrew Gray (Basel)
Primary Examiner: Keli L Hill
Application Number: 29/647,947